Related Experiment Videos
Mild cognitive impairment: clinical characterization and outcome
R C Petersen1, G E Smith, S C Waring
1Department of Neurology, Mayo Clinic, Rochester, Minn 55905, USA.
Archives of Neurology
|April 6, 1999
Summary
Mild cognitive impairment (MCI) subjects show memory deficits distinct from healthy individuals and those with mild Alzheimer's disease (AD). This research characterizes MCI as a distinct clinical entity for potential interventions.
Area of Science:
- Neurology
- Gerontology
- Cognitive Science
Background:
- Mild cognitive impairment (MCI) is characterized by memory loss beyond normal aging but without dementia.
- MCI is a critical focus for predictive studies and early intervention trials.
Purpose of the Study:
- To clinically characterize individuals with mild cognitive impairment (MCI) through cross-sectional and longitudinal assessments.
- To differentiate MCI from healthy controls and mild Alzheimer's disease (AD).
Main Methods:
- A prospective, longitudinal inception cohort study.
- Compared 76 MCI subjects with 234 healthy controls and 106 mild AD patients.
- Utilized comprehensive cognitive assessments and standardized diagnostic criteria for dementia and AD.
Main Results:
- MCI subjects primarily differed from controls in memory, with other cognitive functions being comparable.
- MCI patients showed similar memory performance to very mild AD patients but greater impairment in other cognitive domains.
- Longitudinally, MCI subjects declined cognitively faster than controls but slower than mild AD patients.
Conclusions:
- Mild cognitive impairment (MCI) represents a distinct clinical entity identifiable through cognitive assessments.
- MCI patients can be differentiated from healthy individuals and those with very mild Alzheimer's disease (AD).
- Characterizing MCI is crucial for developing targeted treatment interventions.